The Oncology Institute(TOI) - 2024 Q4 - Earnings Call Transcript

The Oncology Institute (TOI) Q4 2024 Earnings Call March 25, 2025 11:38 PM ET Company Participants Mark Hueppelsheuser - General CounselDaniel Virnich - CEO & Executive DirectorRob Carter - Chief Financial OfficerYuan Zhi - Managing Director Conference Call Participants Robert Leboyer - Senior Biotechnology Analyst Operator Good afternoon, and welcome to the Oncology Institute's Fourth Quarter and Full Year twenty twenty four Earnings Conference Call. Today's call is being recorded and we have allocated one ...